Hodgkin's lymphoma-long-term outcome: An experience from a tertiary care cancer center in North India

Annals of Hematology

Volumn 90, Issue 10, 2011, Pages 1153-1160

  Ganesan, Prasanth ^a   Kumar, Lalit ^a   Raina, Vinod ^a   Sharma, Atul ^a   Bakhshi, Sameer ^a   Sreenivas, Vishnubhatla ^a   Vijayaraghavan, Malini ^a   Thulkar, Sanjay ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Developing countries; Hodgkin's lymphoma; Outcome; Prognostic factors; Survival

Indexed keywords

ALBUMIN; BETAMETHASONE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; ETOPOSIDE; PREDNISOLONE; PREDNISONE; PROCARBAZINE; VINBLASTINE; VINCRISTINE; ALB PROTEIN, HUMAN; SERUM ALBUMIN;

ABSCESS; ADOLESCENT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE MARROW SUPPRESSION; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CARDIOMYOPATHY; CHEMOTHERAPY INDUCED EMESIS; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG RESPONSE; DRUG SAFETY; DRUG TREATMENT FAILURE; FEBRILE NEUTROPENIA; FEMALE; GASTROINTESTINAL DISEASE; HERPES ZOSTER; HISTOPATHOLOGY; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; HYPOTHYROIDISM; INDIA; LONG TERM CARE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MIXED CELLULARITY HODGKIN LYMPHOMA; MULTIPLE CYCLE TREATMENT; NEUROPATHY; NEUTROPENIA; NODULAR SCLEROSIS HODGKIN LYMPHOMA; NONHODGKIN LYMPHOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; SOFT TISSUE DISEASE; TERTIARY HEALTH CARE; ADULT; BLOOD; DEVELOPING COUNTRY; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATHOLOGY; PATHOPHYSIOLOGY; PUBLIC HOSPITAL; RETROSPECTIVE STUDY; SEX RATIO; SURVIVAL;

ADOLESCENT; ADULT; AGED; DEVELOPING COUNTRIES; FEMALE; HODGKIN DISEASE; HOSPITALS, PUBLIC; HUMANS; INDIA; MALE; MIDDLE AGED; NEOPLASM STAGING; OUTPATIENT CLINICS, HOSPITAL; RETROSPECTIVE STUDIES; SERUM ALBUMIN; SEX DISTRIBUTION; SURVIVAL ANALYSIS; YOUNG ADULT;

EID: 80055107190     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1262-8     Document Type: Article

References (32)

1. Bonadonna G (2000) Historical review of Hodgkin's disease. Br J Haematol 110:504-511
2. Diehl V, Thomas RK, Daniel R (2004) Hodgkin's lymphoma- diagnosis and treatment (part II). Lancet Oncol 5(1):19-26 (Pubitemid 38072556)
3. Armitage JO (2010) Early-stage Hodgkin's lymphoma. NEJM 363:653-662
4. Kuruvilla J, Keating A, Crump M (2011) How I treat relapsed and refractory Hodgkin lymphoma? Blood 117(16):4208-4217
5. Shanta V, Sastri DV, Sagar TG, Sasikala K, Krishnamurthi S (1982) A review of Hodgkin's disease at the Cancer Institute, Madras. Clin Oncol 8(1):5-15 (Pubitemid 12148861)
6. Dinshaw K, Pande S, Advani SH, Ramakrishnan G et al (1985) Pediatric Hodgkin's disease in India. J Clin Oncol 3:1605-1612
7. Chandi L, Kumar L, Kochupillai V, Dawar R, Singh R (1998) Hodgkin's disease: a retrospective analysis of 15 years experience at a large referral center. Natl Med J India 11:212-217 (Pubitemid 128549676)
8. Arya LS, Dinand V, Thavaraj V, Bakhshi S, Dawar R, Rath GK, Singh R, Vats TS (2006) Hodgkin's disease in Indian children: outcome with chemotherapy alone. Pediatr Blood Cancer 46:26-34 (Pubitemid 41779314)
9. Raina V, Sharma A, Mohanti BK, Kumar R, Dawar R, Rath GK (2003) Etoposide, vinblastine, adriamycin and prednisolone (EVAP) combination chemotherapy as first-line treatment for Hodgkin's disease. Natl Med J India 16:199-203 (Pubitemid 37304499)
10. Laskar S, Gupta T, Vimal S et al (2004) Consolidation radiation after complete remission in Hodgkin's disease following six cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy: is there a need? J Clin Oncol 22:62-68 (Pubitemid 41095115)
11. Lister TA, Crowther D, Sutcliffe SB et al (1989) Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7:1630-1636 (Pubitemid 19272832)
12. Jaffe ES, Harris NL, Stein H, Vardiman JW (eds) (2001) World Health Organization classification of tumors. Pathology and genetics of tumors of hematopoietic and lymphoid tissues. IARC Press, Lyon
13. Kumar L, Malik PS, Prakash G, Prabu R, Radhakrishnan V, Kayal S, Hariprasad R (2011) Autologous hematopoietic stem cell transplantation-what determines the outcome: an experience from North India. Ann Hematol. doi:10.1007/s00277-011-1205-4
14. Miller AB, Hoogstraten B, Staquet M, Winkler A (1981) Reporting the results of cancer treatment. Cancer 47:207-211
15. Hasenclever D, Diehl V (1998) A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med 339:1506-1514
16. Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S (1993) Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis. Cancer 71(6):2062-2071 (Pubitemid 23068557)
17. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, et al. (2009) SEER Cancer Statistics Review, 1975- 2006, National Cancer Institute. Bethesda, MD. http://seer.cancer. gov/csr/1975-2006/. Based on November 2008 SEER data submission, posted to the SEER web site, 2009. Accessed 21 Mar 2010
18. Vassallo J, Paes RP, Soares FA et al (2005) Histological classification of 1,025 cases of Hodgkin's lymphoma from the State of São Paulo, Brazil. São Paulo Med J 123:134-136 (Pubitemid 40990716)
19. Cheong JW, Park SY, Roh JK, Suh CO, Hahn JS (2006) Treatment of Hodgkin's disease: a twenty-year follow-up of patients at a center in Korea. Yonsei Med J 47:455-465 (Pubitemid 44322970)
20. Dinand V, Dawar R, Arya LS, Unni RS, Mohanty B, Singh R (2007) Hodgkin's lymphoma in Indian children: prevalence and significance of Epstein-Barr virus detection in Hodgkin's and Reed-Sternberg cells. Eur J Cancer 43:161-168 (Pubitemid 46054483)
21. Karnik BS, Nair S (2003) Hodgkin's lymphoma: immunohistochemical features and its association with EBV LMP-1. Experience from a South Indian hospital. Pathology 35:207-211 (Pubitemid 36870594)
22. Glaser SL, Hsu JL (2002) Hodgkin's disease in Asians: incidence patterns and risk factors in population-based data. Leuk Res 26:261-269 (Pubitemid 34037023)
23. Allemani C, Sant M, De Angelis R, Marcos-Gragera R, Coebergh JW (2006) EUROCARE Working Group. Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups. Cancer 107:352-360 (Pubitemid 44036565)
24. Brenner H, Gondos A, Pulte D (2009) Survival expectations of patients diagnosed with Hodgkin's lymphoma in 2006-2010. Oncologist 14:806-813
25. Brenner H, Gondos A, Pulte D (2008) Ongoing improvement in long-term survival of patients with Hodgkin disease at all ages and recent catch-up of older patients. Blood 111:2977-2983
26. Verdecchia A, Francisci S, Brenner H et al (2007) EUROCARE-4 Working Group. Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol 8:784-796 (Pubitemid 47321601)
27. Eichenauer DA, Bredenfeld H, Haverkamp H, Müller H, Franklin J, Fuchs M et al (2009) Hodgkin's lymphoma in adolescents treated with adult protocols: a report from the German Hodgkin Study Group. J Clin Oncol 27:6079-6085
28. Specht L, Nissen NI (1988) Hodgkin's disease stages I and II with infradiaphragmatic presentation: a rare and prognostically unfavourable combination. Eur J Haematol 40(5):396-402
29. Darabi K, Sieber M, Chaitowitz M, Braitman LE, Tester W, Diehl V et al (2005) Infradiaphragmatic versus supradiaphragmatic Hodgkin lymphoma: a retrospective review of 1,114 patients. Leuk Lymphoma 46(12):1715-1720 (Pubitemid 43203104)
30. Gerhartz HH, Beykirch M, Hitter E, Wilmanns W (1993) Chemotherapy dose and survival in advanced Hodgkin's disease. Acta Haematol 89:137-140 (Pubitemid 23247412)
31. Evens AM, Cilley J, Ortiz T et al (2007) G-CSF is not necessary to maintain over 99% dose-intensity with ABVD in the treatment of Hodgkin lymphoma: low toxicity and excellent outcomes in a 10-year analysis. Br J Haematol 137(6):545-552 (Pubitemid 46817335)
32. Boleti E, Mead GM (2007) ABVD for Hodgkin's lymphoma: fulldose chemotherapy without dose reductions or growth factors. Ann Oncol 18(2):376-380 (Pubitemid 46323108)